Status:
UNKNOWN
Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.
Lead Sponsor:
Laval University
Conditions:
COVID-19
Hypoxemia
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department.
Detailed Description
The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department. The quality of oxyg...
Eligibility Criteria
Inclusion
- Hypoxemic patients on automated oxygen therapy during their emergency department stay
- Confirmed or suspected SARS-CoV-2 patients in the emergency department
Exclusion
- Patient on automated oxygen therapy in the emergency department without accessible data of the FreeO2 device.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05235386
Start Date
February 1 2022
End Date
December 1 2022
Last Update
February 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval
Québec, Canada, G1V 4G5